Ftse Mib
38.504,19
2,04%
DAX
23.081,03
3,37%
S&P 500
5.842,63
1,12%
NASDAQ
18.552,73
1,46%
Bitcoin
90.106,73
3,30%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ GRI Bio Inc (GRI) GRI Bio Inc (GRI) Notizie

GRI Bio Inc

GRI
6,91
-0,12 (-1,71%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 22:07:01
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
19/2/202522:08EDGAR2Form 8-K - Current report
19/2/202522:05GLOBEGRI Bio Announces Reverse Stock Split
19/2/202515:00GLOBEGRI Bio, Inc. Participates in the Virtual Investor “Top 5..
11/2/202522:05EDGAR2Form 8-K - Current report
24/1/202523:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202523:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202523:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202522:05EDGAR2Form DEF 14A - Other definitive proxy statements
06/1/202522:58EDGAR2Form S-8 - Securities to be offered to employees in employee..
23/12/202415:00GLOBEGRI Bio Announces European Patent Office Issued a Decision..
20/12/202422:05EDGAR2Form 8-K - Current report
20/12/202422:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
06/12/202414:35GLOBEGRI Bio to Participate in the Virtual Investor Closing Bell..
25/11/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
21/11/202414:45GLOBEGRI Bio Showcases GRI-0621’s Potential to Reduce..
15/11/202422:16EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
14/11/202422:27EDGAR2Form S-3 - Registration statement under Securities Act of..
14/11/202422:24EDGAR2Form 8-K - Current report
14/11/202422:20GLOBEGRI Bio Reports Third Quarter 2024 Financial Results and..
14/11/202422:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
24/10/202414:35EDGAR2Form 8-K - Current report
24/10/202414:30GLOBEGRI Bio Raises a Total of $13.9 Million in Gross Proceeds..
22/10/202422:21EDGAR2Form 8-K - Current report
21/10/202423:35GLOBEGRI Bio Announces Exercise of Warrants
16/10/202414:45GLOBEGRI Bio Presents Positive Preclinical Data Demonstrating..
07/10/202414:30GLOBEGRI Bio to Present at the 22nd International Colloquium on..
30/9/202414:30GLOBEGRI Bio Granted Japan Patent for Proprietary Natural Killer..
26/9/202414:00GLOBEGRI Bio Receives Authorization to Conduct Phase 2a Biomarker..
25/9/202414:45GLOBEGRI Bio (NASDAQ: GRI) to Participate in a Virtual Investor..
18/9/202415:00GLOBEGRI Bio Participates in Virtual Investor KOL Connect Segment
05/9/202414:45GLOBEGRI Bio to Present at the H.C. Wainwright 26th Annual Global..
04/9/202414:45GLOBEGRI Bio to Present at the 2024 European Respiratory Congress
14/8/202414:05GLOBEGRI Bio Reports Second Quarter 2024 Financial Results and..
15/7/202415:05GLOBEGRI Bio (NASDAQ: GRI) to Participate in the Virtual Investor..
11/7/202415:20GLOBEGRI Bio (NASDAQ: GRI) Participates in Virtual Investor “What..
08/7/202415:05GLOBEGRI Bio Regains Compliance with Nasdaq
02/7/202415:05GLOBEGRI Bio Announces Publication of Positive Preclinical Data..
01/7/202414:45GLOBEGRI Bio to Present at the 8th Annual IPF Summit
28/6/202422:05GLOBEGRI Bio Announces Closing of $4.0 Million Public Offering
27/6/202415:00GLOBEGRI Bio Announces Korea Patent Granted for Proprietary..
27/6/202414:00GLOBEGRI Bio Announces Pricing of $4 Million Public Offering
14/6/202414:05GLOBEGRI Bio Announces Reverse Stock Split
11/6/202415:00GLOBEGRI Bio (NASDAQ: GRI) to Present at the Virtual Investor..
22/5/202415:15GLOBEGRI Bio (NASDAQ: GRI) Participates in Virtual Investor “What..
21/5/202414:35GLOBEGRI Bio Presents Positive Preclinical Data from Pipeline of..
20/5/202414:45GLOBEGRI Bio Presents Positive Preclinical Data Demonstrating..
14/5/202415:05GLOBEGRI Bio to Present at Alliance Global Partner’s 2024..
13/5/202414:00GLOBEGRI Bio Reports First Quarter 2024 Financial Results and..
29/4/202414:45GLOBEGRI Bio Announces Abstracts Accepted for Presentation at the..
25/4/202415:15GLOBEGRI Bio to Present at LIVE! with Webull Corporate Connect:..
Apertura: 7,04 Min: 6,82 Max: 7,5786
Chiusura: 7,03

La tua Cronologia

NASDAQ
GRI
GRI Bio
BIT
F14161
Vontobel Financial Produ...
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci